1. Home
  2. ADXN vs SHPH Comparison

ADXN vs SHPH Comparison

Compare ADXN & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • SHPH
  • Stock Information
  • Founded
  • ADXN 2002
  • SHPH 2012
  • Country
  • ADXN Switzerland
  • SHPH United States
  • Employees
  • ADXN N/A
  • SHPH N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • SHPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADXN Health Care
  • SHPH Health Care
  • Exchange
  • ADXN Nasdaq
  • SHPH Nasdaq
  • Market Cap
  • ADXN 10.1M
  • SHPH 2.3M
  • IPO Year
  • ADXN N/A
  • SHPH 2022
  • Fundamental
  • Price
  • ADXN $9.38
  • SHPH $4.00
  • Analyst Decision
  • ADXN Strong Buy
  • SHPH
  • Analyst Count
  • ADXN 1
  • SHPH 0
  • Target Price
  • ADXN $30.00
  • SHPH N/A
  • AVG Volume (30 Days)
  • ADXN 17.4K
  • SHPH 224.2K
  • Earning Date
  • ADXN 08-11-2025
  • SHPH 09-03-2025
  • Dividend Yield
  • ADXN N/A
  • SHPH N/A
  • EPS Growth
  • ADXN N/A
  • SHPH N/A
  • EPS
  • ADXN 0.10
  • SHPH N/A
  • Revenue
  • ADXN $278,508.00
  • SHPH N/A
  • Revenue This Year
  • ADXN $86.57
  • SHPH N/A
  • Revenue Next Year
  • ADXN N/A
  • SHPH N/A
  • P/E Ratio
  • ADXN $0.75
  • SHPH N/A
  • Revenue Growth
  • ADXN N/A
  • SHPH N/A
  • 52 Week Low
  • ADXN $6.51
  • SHPH $3.00
  • 52 Week High
  • ADXN $13.27
  • SHPH $107.40
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 58.20
  • SHPH 45.35
  • Support Level
  • ADXN $8.50
  • SHPH $3.29
  • Resistance Level
  • ADXN $9.87
  • SHPH $4.60
  • Average True Range (ATR)
  • ADXN 0.78
  • SHPH 0.47
  • MACD
  • ADXN 0.05
  • SHPH 0.14
  • Stochastic Oscillator
  • ADXN 72.46
  • SHPH 56.91

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Share on Social Networks: